Savient Pharmaceuticals (SVNT) Tops Q1 Per Share Views

May 5, 2011 7:59 AM EDT
Savient Pharmaceuticals (NASDAQ: SVNT) reported Q1 loss of ($0.19), $0.12 better than the analyst estimate of ($0.31). Revenue for the quarter came in at $1.29 million versus the consensus estimate of $2.09 million.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings